Integrated BioPharma, Inc. (INBP)
0.1821
+0.02
(+12.69%)
USD |
OTCM |
Sep 21, 16:00
Integrated BioPharma Cash from Operations (Annual) : 2.065M for June 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | 2.065M |
| June 30, 2024 | 0.943M |
| June 30, 2023 | 1.232M |
| June 30, 2022 | 4.091M |
| June 30, 2021 | 3.05M |
| June 30, 2020 | 1.339M |
| June 30, 2019 | 0.328M |
| June 30, 2018 | 1.168M |
| June 30, 2017 | 0.397M |
| June 30, 2016 | -0.594M |
| June 30, 2015 | -0.113M |
| June 30, 2014 | 1.877M |
| June 30, 2013 | -1.438M |
| June 30, 2012 | -0.771M |
| Date | Value |
|---|---|
| June 30, 2011 | 0.398M |
| June 30, 2010 | -0.116M |
| June 30, 2009 | -2.556M |
| June 30, 2008 | -4.298M |
| June 30, 2007 | -5.502M |
| June 30, 2006 | 4.678M |
| June 30, 2005 | -4.538M |
| June 30, 2004 | -7.217M |
| June 30, 2003 | -0.1738M |
| June 30, 2002 | 2.772M |
| June 30, 2001 | -1.517M |
| June 30, 2000 | 4.099M |
| June 30, 1999 | -0.4832M |
| June 30, 1998 | -0.4142M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Medifast, Inc. | 6.863M |
| BioForce Nanosciences Holdings, Inc. | -0.0652M |
| Skinvisible, Inc. | -0.0384M |
| Nevis Brands, Inc. | 0.0443M |
| Skinhealth Systems, Inc. | 37.48M |